China approves two coronavirus vaccines for human trials

China approves two coronavirus vaccines for human trials 1 IMG 20200415 012309

China approves two coronavirus vaccines for human trials

The first approved vaccine in China has started its second phase of the trial

China approves two coronavirus vaccines for human trials

China has approved early-stage human tests for two experimental coronavirus vaccines.

State news agency Xinhua reported the breakthrough on Tuesday.

China’s state food and drug administration on Monday approved one vaccine developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech, Wu said.

China approves two coronavirus vaccines for human trials 2 IMG 20200415 005708

 

Another vaccines are being developed by Sinovac Biotech and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.

China’s National Health Commission has confirmed the trials will go ahead.

Work on the trials on the global pandemic commenced in March 2020.

“We can confirm now that three particular vaccines are being tested in China, and the National Health Commission has said it will have to clear several conditions before they can enable mass production of the vaccines globally,” Al-Jazeera’s Sarah Clarke reported

“A total of 500 people signed up to volunteer for that in the first phase, which looked at the safety of this vaccine, and the second phase has now introduced a placebo control group,” she said.

Coronavirus has claimed over 120,000 lives and affected nearly 2 million people.

On Monday, China reported the highest number of new coronavirus cases in over five weeks.

As of Tuesday, China reported 82,249 coronavirus cases and 3,341 deaths. There were no fatalities over the past 24 hours.

The country is battling to prevent more COVID-19 infections, weeks after containing the outbreak.

 

Leave a Reply

Your email address will not be published. Required fields are marked *